Whilst high B12 itself is not typically harmful, it may indicate an underlying condition requiring investigation and management
Patients had a mean age of 48 years (range: 20 to 76 years), 67% were male, 66% were White, 20% were Asian, 8% were American Indian/Alaska Native, and 6% were Black or African American
Close FIP monitoring of the cat's condition, including regular blood work, is crucial to assess the effectiveness of the fip treatment regimen
Retatrutide is an investigational triple incretin receptor agonist under clinical development by Eli Lilly, whilst 5-Amino-1MQ is a research chemical targeting the NNMT enzyme
Interference with Assays : Certain conditions and medications can affect the accuracy of serum B12 assays
These treatments are intended for adults with a BMI of 30 or above, or a BMI of 27 or above with a weight-related condition such as type 2 diabetes, high blood pressure or high cholesterol